Gilliland Jeter Wealth Management LLC 89bio, Inc. Transaction History
Gilliland Jeter Wealth Management LLC
- $296 Billion
- Q4 2024
A detailed history of Gilliland Jeter Wealth Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Gilliland Jeter Wealth Management LLC holds 39,439 shares of ETNB stock, worth $336,020. This represents 0.1% of its overall portfolio holdings.
Number of Shares
39,439
Previous 46,159
14.56%
Holding current value
$336,020
Previous $342 Million
9.71%
% of portfolio
0.1%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding ETNB
# of Institutions
173Shares Held
125MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$141 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$121 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$86.9 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$63.7 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$59.8 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $396M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...